Patent · US Expired

Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same

US6365155B1 · kind B1 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 30, 1999
Grant dateApr 2, 2002
Priority date
Expiry dateDec 30, 2019

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/96433
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof are used in pharmaceutical preparations and in diagnosis. Cells which express these antibodies, antibody fragments, mixtures or derivatives thereof are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.